Birth Control Options and Side Effects: Pills, IUDs, Implants and Emergency Contraception

Evidence reviewed: 8 November 2026. Choosing contraception (birth control) is a personal healthcare decision. Options include hormonal and copper intrauterine devices (IUDs), implants, pills, patches, vaginal rings, injections, condoms, fertility-awareness methods and permanent procedures. They differ in effectiveness, side effects, menstrual effects, reversibility, ease of use and suitability for particular medical conditions. The CDC U.S. Medical Eligibility Criteria (MEC) and Selected Practice Recommendations (SPR), updated in 2024, emphasize individual choice and removing unnecessary barriers to care—not prescribing one method for everyone [1–3].

How does contraception prevent pregnancy?

Methods work through different mechanisms. Combined estrogen–progestin methods generally suppress ovulation. Progestin-only methods can thicken cervical mucus, alter the uterine lining and sometimes suppress ovulation, depending on the formulation. Copper IUDs interfere with sperm function and fertilization. Condoms create a physical barrier, while fertility-awareness approaches aim to avoid unprotected intercourse during fertile periods. Emergency contraception is used after unprotected sex or contraceptive failure [1,2].

These methods generally prevent pregnancy rather than interrupt an established pregnancy. Choosing one also involves whether protection from sexually transmitted infections (STIs), including HIV, is needed.

Which methods are most effective with typical use?

Typical use includes missed pills, delayed injections or imperfect condom use. Long-acting reversible contraception requires much less daily action, so typical-use effectiveness is generally higher. The figures below are approximate first-year pregnancy rates, not a guarantee for an individual [3].

Method Approximate typical-use pregnancy rate Important considerations
Contraceptive implant About 0.1% Very effective; irregular bleeding may occur; duration depends on product and approval.
Levonorgestrel IUD About 0.1–0.4% Often reduces menstrual bleeding and cramps; inserted by a trained clinician.
Copper IUD About 0.8% Hormone-free; may increase bleeding or cramps, especially initially.
Contraceptive injection About 4% Repeat on schedule; menstrual changes and delayed fertility return can occur.
Combined pill, patch or ring About 7% Requires regular use; estrogen-related contraindications must be reviewed.
External condom About 13% Helps protect against pregnancy and STIs; use correctly every time.

Other methods, including internal condoms, diaphragms and fertility-awareness approaches, have different typical-use effectiveness that depends substantially on correct technique and consistent use. Permanent contraception, such as vasectomy or tubal surgery, requires informed counseling about permanence and alternatives [2,3].

Combined hormonal contraception: pills, patches and rings

Combined hormonal contraceptives (CHCs) contain an estrogen and progestin. They can make periods more predictable and may reduce menstrual cramps or improve acne for some patients. Possible side effects include nausea, breast tenderness, breakthrough bleeding and headaches, often improving with time. Important but uncommon risks include venous thromboembolism and arterial events in susceptible users [1].

For individuals with migraine with aura, the CDC classifies CHCs as MEC category 4—an unacceptable health risk. CHCs are also inappropriate in some patients with current breast cancer, major thrombotic conditions or uncontrolled severe hypertension. Smoking at age 35 or older also changes eligibility, particularly with heavy cigarette use [1]. A clinician should assess blood pressure, medical history and potential drug interactions before prescribing estrogen-containing contraception.

Progestin-only pills and the implant

Progestin-only pills (POPs) avoid estrogen and may be appropriate when estrogen is unsuitable. Available formulations include norethindrone, norgestrel and drospirenone; their instructions for timing, missed doses and backup contraception are not identical. Follow the specific product and CDC SPR guidance rather than applying one universal “three-hour pill window” to every POP [2].

The etonogestrel implant is a small rod inserted under the skin of the upper arm. It provides highly effective contraception for a product- and country-specific duration. Unpredictable spotting, prolonged bleeding or amenorrhea can occur; bleeding changes are not necessarily dangerous, but new or persistent problems should be assessed. Certain enzyme-inducing medicines may reduce the effectiveness of some hormonal contraceptives; a pharmacist can review combinations [1,2].

Hormonal and copper IUDs

Levonorgestrel-releasing IUDs offer highly effective contraception and frequently reduce heavy menstrual bleeding, although irregular spotting is common early on. They last approximately 3–8 years depending on the device and local authorization [3].

The copper IUD is hormone-free and can provide contraception for many years, commonly up to 10 years for a standard device. It can increase menstrual flow or cramps in some people, while the LNG-IUD often lessens these symptoms. Both require insertion by a trained clinician. Insertion discomfort, expulsion, perforation and infection-related considerations should be explained realistically; serious insertion complications are uncommon [1,2].

Neither IUD protects against STIs. People at STI risk can use condoms alongside an IUD. Modern guidance does not require unnecessary routine pre-insertion tests or visits when clinically unsuitable, but pregnancy assessment and evaluation of relevant genital infection signs remain important [2].

Contraceptive injections

Depot medroxyprogesterone acetate (DMPA) is administered on a regular schedule, often every three months for intramuscular formulations. Some users experience irregular bleeding followed by lighter or absent periods. Potential concerns include weight change, decreased bone mineral density during use and a sometimes delayed return to fertility after stopping. These issues require individualized counseling rather than treating DMPA as unsafe for every young person or suitable for every medical condition [1,2].

Condoms and STI prevention

External and internal condoms can reduce the risk of pregnancy and many STIs when used correctly and consistently. This is a distinctive advantage over hormonal contraception and IUDs. Using condoms with another effective method—sometimes called dual protection—may help people who want both pregnancy prevention and STI risk reduction [3].

Avoid oil-based lubricants with latex condoms, as they can weaken the material. Discuss latex allergy, product compatibility and how to use condoms correctly. Emergency contraceptive pills do not protect against STIs; recent HIV exposure may warrant urgent assessment for post-exposure prophylaxis.

Which contraceptives are suitable during breastfeeding?

Eligibility depends on time since delivery, breastfeeding status, clotting risk and the method. The CDC MEC provides different categories for estrogen-containing and progestin-only contraceptives during the postpartum period. For example, CHCs should not be used during the first 21 days postpartum in breastfeeding patients under U.S. MEC, while some progestin-only methods may be started earlier depending on circumstances [1].

Do not assume that breastfeeding alone always prevents pregnancy. Lactational amenorrhea is an effective temporary method only if all three criteria are met: the person is less than six months postpartum, has no return of menses, and is fully or nearly fully breastfeeding. If any criterion is no longer met, discuss another method [2].

Emergency contraception: what to do after unprotected sex

Emergency contraception can be considered after a broken condom, missed contraception or unprotected intercourse. The CDC SPR describes the following options [2,4]:

Method When it can be used Important follow-up
Copper IUD Generally within five days of the first episode of unprotected intercourse; additional timing rules apply when ovulation can be estimated. Very effective and can remain for ongoing contraception.
Ulipristal acetate (UPA) 30 mg As soon as possible within five days. Generally wait at least five days before starting/resuming hormonal contraception; use backup as instructed.
Levonorgestrel (LNG) 1.5 mg As soon as possible within five days; effectiveness declines with delay, especially after three days. Regular hormonal contraception can usually start immediately, with backup as indicated.

UPA may work better than LNG on days three to five after unprotected sex. Body weight, interacting medicines and availability may influence selection. After using UPA, the CDC advises delaying hormonal contraception for at least five days and then using condoms or avoiding intercourse for seven days after starting regular hormonal contraception, or until the next period if sooner. A pregnancy test is advised if no withdrawal bleeding occurs within three weeks [2,4]. Seek local clinical or pharmacy guidance promptly: the sooner emergency contraception is arranged, the better.

How to choose a method based on personal priorities

  • Highest effectiveness with little daily effort: consider an implant or IUD if clinically suitable.
  • Heavy or painful periods: a levonorgestrel IUD or certain hormonal methods may provide noncontraceptive benefits.
  • Preference to avoid hormones: copper IUD or appropriate barrier methods may fit, with discussion of menstrual effects.
  • Migraine with aura or clotting risk: estrogen-containing methods may be contraindicated; assess alternatives using MEC.
  • Breastfeeding/postpartum: method timing and eligibility depend on current postpartum circumstances.
  • STI protection: use condoms, with or without another method, as appropriate.
  • Future pregnancy plans: discuss reversibility and the potentially delayed return of ovulation after DMPA.

Common misconceptions

Does an IUD cause infertility?

No. Modern IUDs do not routinely cause permanent infertility. Fertility generally returns after removal, though underlying health and age still matter [1,2].

Does every hormonal contraceptive contain estrogen?

No. Progestin-only pills, implants, hormonal IUDs and DMPA avoid estrogen and have different eligibility profiles.

Is contraception always effective if used perfectly?

No method is perfect. Typical-use failure differs from perfect use, particularly for methods relying on regular user action.

Do emergency contraceptive pills cause an abortion?

No. They are used to prevent pregnancy after intercourse and do not terminate an established pregnancy.

Can I choose contraception without discussing other medicines?

Medication review matters: some antiepileptics, rifamycins and other enzyme-inducing medicines can reduce the effectiveness of certain hormonal methods [1].

Key takeaways

The best contraceptive is one that is safe, effective and acceptable for the individual. Consider effectiveness, menstrual effects, risks, convenience, reversibility and STI protection. Use CDC MEC/SPR guidance to avoid both unsafe choices and unnecessary restrictions. Emergency options should be accessed promptly when needed.

References

  1. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR. 2024;73(RR-4):1–126.
  2. Centers for Disease Control and Prevention. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWR. 2024;73(RR-3):1–79.
  3. Centers for Disease Control and Prevention. Contraception and birth control methods: effectiveness and options. Accessed 8 Nov 2026.
  4. Centers for Disease Control and Prevention. Emergency contraception: U.S. Selected Practice Recommendations. Accessed 8 Nov 2026.

Medical disclaimer: General educational information, not an individual contraception prescription. Method eligibility depends on medical history, medications, pregnancy and postpartum circumstances. Seek urgent professional guidance after unprotected intercourse when emergency contraception is needed or after possible STI exposure.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *